
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link